Trust in digital varies among health professionals: study

Share this article:
Trust in digital varies among health professionals: study
Trust in digital varies among health professionals: study

Health marketing communications firm Enspektos did a deep dive into desktop and media habits and found that who you are in the healthcare industry plays a big role in  how much you trust the information that pops up on the screen.

The overall trend was that doctors, nurses and pharmacists trust information from health websites they access from desktops much more than they do information they access using mobile platforms or social networks. Twitter was deemed the least credible.

How much a health professional thought of each information channel was partly linked to job title, with 78% of polled doctors saying they trusted websites, compared with 69% of nurses and 71% of pharmacists.

Mobile content was considered credible by 70% of the polled doctors, but only by 46% of nurses and 61% of pharmacists. Social network information wasn't nearly as highly regarded, with only 10% of the polled docs saying it was trustworthy, compared with 9% of polled nurses and 6% of polled pharmacists.

The study also showed that low social media trust doesn't mean pharma should stay away from the communal space—the report found that these same healthcare providers changed their minds about the integrity of social-media news if they dipped into the social space while doing work-related web surfing or just after scanning websites for related health information.
Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Private View: Creating Compelling Experiences

Private View: Creating Compelling Experiences

In today's multi-channel environment, game-changing ideas blend creativity and sensory ideation to create a meaningful customer experience

Putting consumers at the center of your universe

Putting consumers at the center of your universe

The question should be: How do you simplify and identify the moments that mean the most to customers?

Did "pay-to-play" confab help Zohydro approval?

Did "pay-to-play" confab help Zohydro approval?

US senators Joe Manchin (D-WV) and David Vitter (R-LA) are asking whether a "pay-to-play" meeting between drug industry executives and FDA officials influenced the agency's approval of Zohydro